PUBLISHER: Grand View Research | PRODUCT CODE: 1376000
PUBLISHER: Grand View Research | PRODUCT CODE: 1376000
The global angioplasty balloons market size is expected to reach USD 3.24 billion by 2030, registering a CAGR of 3.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. This growth is attributed to favorable government policies and increasing coronary and peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high-cost stent placements. Furthermore, advancements in angioplasty balloons and expanding geographical reach are likely to propel the market growth in the coming years.
For instance, in December 2014, Medtronic plc received an FDA approval for their drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. The company also received product approval from Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Approval and commercialization of cutting and scoring balloons, such as TREK and MINI TREK, AngioSculpt, and Flextome balloons along with rising adoption of new balloons are likely to drive the market further.